Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL6ST | P40189 | 5/20 | 0.56 |
| ▸ | STAT3 | P40763 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 7/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6601336 | 0.94 | IL6ST (0.54) | IL6STSTAT3IDH1NAAAAGTR2 | |
| SCHEMBL2070699 | 0.94 | IL6ST (0.54) | IL6STSTAT3IDH1NAAAAGTR2 | |
| SCHEMBL20695126 | 0.86 | PPARA (0.47) | IL6STIDH1NAAAAGTR2FAAH | |
| SCHEMBL19423219 | 0.86 | PPARA (0.47) | IL6STIDH1NAAAAGTR2FAAH | |
| SCHEMBL20695124 | 0.86 | PPARA (0.47) | IL6STIDH1NAAAAGTR2FAAH | |
| SCHEMBL19423252 | 0.86 | PPARA (0.47) | IL6STIDH1NAAAAGTR2FAAH | |
| SCHEMBL20695123 | 0.86 | PPARA (0.47) | IL6STIDH1NAAAAGTR2FAAH | |
| SCHEMBL8826143 | 0.83 | IL6ST (0.59) | IL6STSTAT3IDH1NAAAFAAH | |
| SCHEMBL7359508 | 0.83 | IL6ST (0.55) | IL6STSTAT3IDH1NAAAFAAH | |
| SCHEMBL7359514 | 0.83 | IL6ST (0.55) | IL6STSTAT3IDH1NAAAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630410-A1 | POLQ INHIBITORS | Astrazeneca AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121753-A1 | POLQ INHIBITORS | ASTRAZENECA AB (SE) | 2024-06-13 | — | — | WO | disclosed |